Axitinib studies presented at ASCO-GU '19 with simultaneous NEJM publication are discussed, followed by a brief overview (18:50) of darolutamide, a new anti-androgen, and its drug interaction potential.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
